Dusseldorf - Delayed Quote EUR

Bactiguard Holding AB (5JE.DU)

Compare

2.8000

-0.0300

(-1.06%)

As of 12:31 PM GMT+1. Market Open.

Currency in SEK All numbers in thousands

Download

Breakdown

TTM

12/31/2023

12/31/2022

12/31/2021

12/31/2020

Total Revenue

235,773.0000

203,990.0000

226,721.0000

169,486.0000

172,315.0000

Cost of Revenue

45,969.0000

64,009.0000

43,416.0000

38,683.0000

35,194.0000

Gross Profit

189,804.0000

139,981.0000

183,305.0000

130,803.0000

137,121.0000

Operating Expense

244,512.0000

277,175.0000

237,532.0000

185,115.0000

156,558.0000

Operating Income

-54,708.0000

-137,194.0000

-54,227.0000

-54,312.0000

-19,437.0000

Net Non Operating Interest Income Expense

-8,864.0000

-8,277.0000

-8,897.0000

-10,307.0000

-7,730.0000

Pretax Income

-65,255.0000

-147,154.0000

-59,855.0000

-63,252.0000

-41,933.0000

Tax Provision

-9,144.0000

-8,772.0000

-6,978.0000

-4,479.0000

-3,544.0000

Net Income Common Stockholders

-56,111.0000

-138,382.0000

-52,876.0000

-58,773.0000

-38,388.0000

Diluted NI Available to Com Stockholders

-56,111.0000

-138,382.0000

-52,876.0000

-58,773.0000

-38,388.0000

Basic EPS

-1.60

-3.95

-1.51

-1.68

-1.14

Diluted EPS

-1.60

-3.95

-1.51

-1.68

-1.14

Basic Average Shares

35,043.8850

33,543.8850

Diluted Average Shares

35,043.8850

33,543.8850

Total Operating Income as Reported

-49,447.0000

-131,933.0000

-55,667.0000

-54,188.0000

-17,638.0000

Total Expenses

290,481.0000

341,184.0000

280,948.0000

223,798.0000

191,752.0000

Net Income from Continuing & Discontinued Operation

-56,111.0000

-138,382.0000

-52,876.0000

-58,773.0000

-38,388.0000

Normalized Income

-56,111.0000

-138,382.0000

-52,862.7487

-58,469.1555

-28,069.5773

Interest Income

-951.0000

5,243.0000

1,174.0000

4.0000

25.0000

Interest Expense

7,921.0000

13,528.0000

8,697.0000

8,373.0000

8,809.0000

Net Interest Income

-8,864.0000

-8,277.0000

-8,897.0000

-10,307.0000

-7,730.0000

EBIT

-57,334.0000

-133,626.0000

-51,158.0000

-54,879.0000

-33,124.0000

EBITDA

-2,542.0000

-77,761.0000

-1,918.0000

-7,875.0000

11,169.0000

Reconciled Cost of Revenue

45,969.0000

64,009.0000

43,416.0000

38,683.0000

35,194.0000

Reconciled Depreciation

26,409.0000

39,602.0000

49,240.0000

47,004.0000

44,293.0000

Net Income from Continuing Operation Net Minority Interest

-56,111.0000

-138,382.0000

-52,876.0000

-58,773.0000

-38,388.0000

Total Unusual Items Excluding Goodwill

-15.0000

-327.0000

-11,271.0000

Total Unusual Items

-15.0000

-327.0000

-11,271.0000

Normalized EBITDA

-2,542.0000

-77,761.0000

-1,903.0000

-7,548.0000

22,440.0000

Tax Rate for Calcs

0.0001

Tax Effect of Unusual Items

-1.7487

-23.1555

-952.5773

12/31/2020 - 2/16/2024

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

7D2A.F Sedana Medical AB (publ)

0.8930

-1.11%

4ZG.DU Median Technologies

3.9200

-2.73%

2X7.F OrthoPediatrics Corp.

21.00

0.00%

8BD.SG Boule Diagnostics AB (publ)

0.7100

-1.93%

8HH.DU Avanos Medical Inc

16.80

-1.75%

6GJ.DU Glaukos Corp

128.00

-0.78%

5HJ.F enVVeno Medical Corporation

3.1000

+0.65%

4PC.F Perimeter Medical Imaging AI, Inc.

0.3800

+15.85%

6YC.F Senzime AB (publ)

0.4735

0.00%

7AC.F Acarix AB (publ)

0.0198

-1.00%

News

Life

Entertainment

Finance

Sports

New on Yahoo

Yahoo Finance

Bactiguard Holding AB (5JE.DU)

Upgrade to begin using 40 years of financial statements and get so much more.

Related Tickers